Estrogen (ER) and progesterone (PR) receptors and human epidermal growth factor receptor 2 (HER2) are the classic tumor markers for breast carcinoma with a direct effect on treatment decisions [1, 2]. The gene discussed is ERBB2; the disease is neoplasm.